Clinical Trial Update: Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating neratinib combined with temsirolimus in solid tumors has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Carcinoma
• Neoplasms

Drugs mentioned

• Temsirolimus (temsirolimus)
• neratinib (neratinib)

Snippet

Sponsor: Puma Biotechnology, Inc. | Conditions: Neoplasms, Malignant Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2018-02-26